Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of avatrombopag in subjects with chemotherapy-induced thrombocytopenia receiving chemotherapy for the treatment of ovarian, lung (small cell and non-small cell) and bladder cancer.
Epistemonikos ID: 9205c9c3a3cfa1c42277c04b25990a3ad2fdc6ac
First added on: May 21, 2024